Brief: Dr Reddy's Launches Oral Semaglutide Biosimilar Obeda In India
20/05/2026 12:24
May 20 (Reuters) - Dr Reddy's Laboratories Ltd REDY.NS: ANNOUNCES LAUNCH OF ORAL SEMAGLUTIDE BIOSIMILAR OBEDA IN INDIA OBEDA PRICED AT 99, 135, AND 225 RUPEES PER TABLET FOR 3 MG, 7 MG,14 MG DOSES, RESPECTIVELY Source text: [ID:] Further company coverage: REDY.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dr. Reddy's Laboratories
See all newsDr Reddy's rolls out new generic Ozempic brands to ease Obeda supply hit
Dr Reddy's beats quarterly profit estimate on India market lift (updated)
India's Dr Reddy's beats quarterly profit estimate
Brief: Dr. Reddy's Q2 Consol Net PAT 9.25 Billion Rupees
Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruption